Image_2_Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24highCD38high Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders.jpeg
The cellular mechanisms involved in the lack of protective antibody response after hepatitis B vaccination are still rather unclear. Regulatory B cells (Breg) known as modulators of B-and T-cell responses may contribute to poor vaccine responsiveness. The current study aimed to investigate the role of regulatory B cells (Breg) in hepatitis B vaccine non-responsiveness after immunization with second- or third-generation hepatitis B vaccines.
MethodWe performed comparative phenotypic and frequency analysis of Breg subsets (CD24+CD27+ and CD24highCD38high Breg) in second-generation hepatitis B vaccine non-responders (2nd HBvac NR, n = 11) and responders (2nd HBvac R, n = 8) before (d0), on day 7 (d7), and 28 (d28) after booster vaccination. Cryopreserved peripheral blood mononuclear cells were stimulated ex vivo with a combination of CpG, PMA, and Ionomycin (CpG+P/I) and analyzed for numbers and IL-10 expression levels of Breg by flow cytometry-based analyses.
ResultsFlow cytometry-based analyses revealed elevated frequencies of CD24+CD27+ Breg at all time points and significantly higher frequencies of CD24highCD38high Breg on d0 (p = 0.004) and 28 (p = 0.012) in 2nd HBvac NR compared to 2nd HBvac R. In parallel, we observed significantly lower levels of CpG+P/I-induced IL-10 expression levels of CD24+CD27+ and CD24highCD38high Breg (d0: p < 0.0001; d7: p = 0.0004; d28: p = 0.0003 and d0: p = 0.016; d7: p = 0.016, respectively) in 2nd HBvac NR compared to 2nd HBvac R before and after booster immunization.
Frequencies of CD24+CD27+ and CD24highCD38high Breg significantly decreased after third-generation hepatitis B booster vaccination (d7: p = 0.014; d28: p = 0.032 and d7: p = 0.045, respectively), whereas IL-10 expression levels of both Breg subsets remained stable.
ConclusionHere we report significantly higher frequencies of CD24highCD38high Breg in parallel with significantly lower IL-10 expression levels of CD24+CD27+ and CD24highCD38high Breg in 2nd HBvac NR compared to 2nd HBvac R. Anti-HBs seroconversion accompanied by a decrease of Breg numbers after booster immunization with a third-generation hepatitis B vaccine could indicate a positive effect of third-generation hepatitis B vaccines on Breg-mediated immunomodulation in hepatitis B vaccine non-responders.
History
References
- https://doi.org//10.1093/epirev/mxj009
- https://doi.org//10.1016/j.vaccine.2008.09.056
- https://doi.org//10.1086/589722
- https://doi.org//10.1002/jmv.20524
- https://doi.org//10.3748/wjg.v20.i30.10383
- https://doi.org//10.1007/s00705-019-04369-9
- https://doi.org//10.1016/j.vaccine.2006.01.007
- https://doi.org//10.1016/j.vaccine.2004.02.046
- https://doi.org//10.1016/s1386-6532(03)00087-8
- https://doi.org//10.1002/hep.20740
- https://doi.org//10.1016/j.vaccine.2006.04.016
- https://doi.org//10.1016/S0140-6736(02)11083-X
- https://doi.org//10.1080/21645515.2016.1274475
- https://doi.org//10.1038/srep27251
- https://doi.org//10.1371/journal.pone.0082779
- https://doi.org//10.1046/j.1365-2249.1996.d01-732.x
- https://doi.org//10.1007/BF00163994
- https://doi.org//10.1016/s0264-410x(01)00007-x
- https://doi.org//10.1016/s0198-8859(97)00209-7
- https://doi.org//10.1046/j.1365-2249.2003.02093.x
- https://doi.org//10.1046/j.1365-3083.2002.01057.x
- https://doi.org//10.2147/JIR.S286426
- https://doi.org//10.1016/j.meegid.2021.104753
- https://doi.org//10.1371/journal.pone.0151761
- https://doi.org//10.3389/fimmu.2017.00201
- https://doi.org//10.1111/all.14763
- https://doi.org//10.1016/j.immuni.2015.04.005
- https://doi.org//10.3389/fimmu.2017.01951
- https://doi.org//10.1111/1348-0421.12636
- https://doi.org//10.1182/blood-2010-07-294249
- https://doi.org//10.3892/mmr.2017.6507
- https://doi.org//10.1038/cmi.2012.60
- https://doi.org//10.4049/jimmunol.1103139
- https://doi.org//10.1016/j.molimm.2014.01.014
- https://doi.org//10.1080/21645515.2018.1441653
- https://doi.org//10.4049/jimmunol.1300293
- https://doi.org//10.1186/s12967-016-0932-7
- https://doi.org//10.1007/s00103-013-1845-8
- https://doi.org//10.1016/s0264-410x(98)00203-5
- https://doi.org//10.1016/j.jaci.2013.01.014
- https://doi.org//10.1002/eji.201343822
- https://doi.org//10.1016/j.coi.2014.02.009
- https://doi.org//10.1016/s0168-8278(00)00082-9
- https://doi.org//10.1007/s00430-014-0374-x
- https://doi.org//10.1016/j.vaccine.2014.06.076
- https://doi.org//10.1007/s10157-017-1416-7
- https://doi.org//10.1016/0264-410x(92)90067-t
- https://doi.org//10.1111/j.1399-0039.1997.tb02827.x
- https://doi.org//10.1053/jhep.2001.27564
- https://doi.org//10.1016/j.vaccine.2010.07.058
- https://doi.org//10.1002/hep.510310237
- https://doi.org//10.1016/j.patbio.2009.11.001
- https://doi.org//10.1146/annurev.iy.07.040189.001045
- https://doi.org//10.1016/0167-5699(96)80606-2
- https://doi.org//10.1016/s0264-410x(00)00084-0
- https://doi.org//10.1046/j.1365-2567.2001.01273.x
- https://doi.org//10.1016/j.virol.2004.04.042
- https://doi.org//10.1016/j.vaccine.2008.08.054
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity